World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
93
Citations
32272
World Ranking
10875
National Ranking
391

Overview

Giovanni Paganelli is affiliated with the Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori in Italy. Their research is primarily situated within the field of Medicine with a focus on several specialized subfields including Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Oncology, Cancer Research, and Epidemiology.

The scientist's work covers a variety of topics, notable among them are:

  • Prostate Cancer Treatment and Research
  • Radiopharmaceutical Chemistry and Applications
  • Prostate Cancer Diagnosis and Treatment
  • Medical Imaging Techniques and Applications
  • Neuroendocrine Tumor Research Advances
  • Lung Cancer Research Studies
  • Neuroblastoma Research and Treatments

Giovanni Paganelli has contributed to multiple publications, with papers appearing frequently in certain scientific venues. Key publication venues include:

  • European Journal of Nuclear Medicine and Molecular Imaging
  • Journal of Clinical Oncology
  • Physica Medica
  • Frontiers in Oncology
  • Scientific Reports

Among their recent papers are:

  • Dosimetry and safety of 177Lu PSMA-617 along with polyglutamate parotid gland protector: preliminary results in metastatic castration-resistant prostate cancer patients, 2020, European Journal of Nuclear Medicine and Molecular Imaging
  • Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study, 2020, European Journal of Nuclear Medicine and Molecular Imaging
  • Combined use of 177Lu-DOTATATE and metronomic capecitabine (Lu-X) in FDG-positive gastro-entero-pancreatic neuroendocrine tumors, 2021, European Journal of Nuclear Medicine and Molecular Imaging
  • Peptide receptor radionuclide therapy in patients with metastatic progressive pheochromocytoma and paraganglioma: long-term toxicity, efficacy and prognostic biomarker data of phase II clinical trials, 2021, ESMO Open
  • Optimizing PSMA Radioligand Therapy for Patients with Metastatic Castration-Resistant Prostate Cancer. A Systematic Review and Meta-Analysis, 2020, International Journal of Molecular Sciences

Frequent collaborators in their research include:

  • Federica Matteucci
  • Anna Sarnelli
  • Valentina Di Iorio
  • Stefano Severi
  • Paola Caroli

The breadth of publications spans 181 works in medicine, with significant contributions to imaging techniques and oncological studies. The scientist's research presents an emphasis on radiopharmaceutical applications and treatments for prostate cancer alongside investigations into neuroendocrine tumors and lung cancer.

Best Publications

  • A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer.

    Umberto Veronesi;Giovanni Paganelli;Giuseppe Viale;Alberto Luini

  • Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.

    Umberto Veronesi;Giovanni Paganelli;Viviana Galimberti;Giuseppe Viale

  • Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series.

    U Veronesi;G Paganelli;G Viale;V Galimberti

  • Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study.

    Umberto Veronesi;Giuseppe Viale;Giovanni Paganelli;Stefano Zurrida

  • Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study

    Umberto Veronesi;Giovanni Paganelli;Giuseppe Viale;Giuseppe Viale;Alberto Luini;Alberto Luini

  • Overview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin Analogs

    Dik J Kwekkeboom;Jan Mueller-Brand;Giovanni Paganelli;Lowell B Anthony

  • Use of technetium-99m-labeled colloid albumin for preoperative and intraoperative localization of nonpalpable breast lesions

    Roberto Gennari;Viviana Galimberti;Concetta De Cicco;Stefano Zurrida

  • Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study

    Lisa Bodei;Marta Cremonesi;Chiara M. Grana;Nicola Fazio

  • Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors.

    Lisa Bodei;Marta Cremonesi;Mahila Ferrari;Monica Pacifici

  • Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors

    Lisa Bodei;Mark Kidd;Giovanni Paganelli;Chiara M. Grana

  • Radioguided Sentinel Lymph Node Biopsy in Breast Cancer Surgery

    G Mariani;L Moresco;G Viale;G Villa

  • Antibody Pretargeting Advances Cancer Radioimmunodetection and Radioimmunotherapy

    David M. Goldenberg;Robert M. Sharkey;Giovanni Paganelli;Jacques Barbet

  • Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: A phase I study

    Lisa Bodei;Marta Cremonesi;Stefania Zoboli;Chiara Grana

  • Three-Step Monoclonal Antibody Tumor Targeting in Carcinoembryonic Antigen-positive Patients

    G. Paganelli;P. Magnani;F. Zito;E. Villa

  • Predicting the Risk for Additional Axillary Metastases in Patients With Breast Carcinoma and Positive Sentinel Lymph Node Biopsy

    Giuseppe Viale;Eugenio Maiorano;Giancarlo Pruneri;Mauro G. Mastropasqua

  • 111In- and 90Y-DOTA-Lanreotide: Results and implications of the MAURITIUS trial

    Irene Virgolini;Keith Britton;John Buscombe;Roy Moncayo

  • Receptor radionuclide therapy with 90Y-[DOTA]0-Tyr3-octreotide (90Y-DOTATOC) in neuroendocrine tumours.

    Lisa Bodei;Marta Cremonesi;Chiara Grana;Paola Rocca

  • Receptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotide

    Giovanni Paganelli;Stefania Zoboli;Marta Cremonesi;Lisa Bodei

  • Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer.

    Concetta De Cicco;Marta Cremonesi;Alberto Luini;Mirco Bartolomei

  • Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes

    U. Veronesi;G. Paganelli;V. Galimberti;G. Viale

Frequent Co-Authors

Giuseppe Viale
Giuseppe Viale University of Milan
Umberto Veronesi
Umberto Veronesi European Institute of Oncology
Viviana Galimberti
Viviana Galimberti European Institute of Oncology
Paolo Veronesi
Paolo Veronesi European Institute of Oncology
Giovanni Martinelli
Giovanni Martinelli University of Bologna
Antonio G. Siccardi
Antonio G. Siccardi IRCCS Ospedale San Raffaele
Ugo De Giorgi
Ugo De Giorgi The University of Texas MD Anderson Cancer Center
Irvin M. Modlin
Irvin M. Modlin Yale University
Patrick Maisonneuve
Patrick Maisonneuve European Institute of Oncology
F. Fazio
F. Fazio University of Milano-Bicocca

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative pathways in healthcare can help you enter the workforce faster or expand your career options. Many students consider combining online education with traditional routes to medical careers, thanks to flexibility and affordability.

Nursing remains a highly sought-after field for those interested in patient care. If you’re searching for a cost-effective way to advance, explore cheap rn to bsn programs to study from home while upgrading your credentials. For those who already have a non-nursing bachelor’s degree, direct entry msn online programs offer an accelerated route to advanced nursing roles.

If you’re looking to take your first step into healthcare, you might wonder what is the easiest nursing program to get into. Knowing your options may help open doors to nursing programs suited to your background.

For those more interested in administrative roles, accredited medical billing and coding schools online allow you to train for in-demand jobs without direct patient care. These diverse educational routes support different lifestyles and career goals in the healthcare domain.

Best Scientists Citing Giovanni Paganelli

Trending Scientists